Gaceta Médica de México

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board

>Journals >Gaceta Médica de México >Year 2015, Issue 2

Membrila-Mondragón J, Staines-Boone AT, Sánchez-Sánchez LM, Ruiz-Pedraza MD
Pulmonary complications in pediatric patients with primary immunodeficiency (PI)
Gac Med Mex 2015; 151 (2)

Language: Español
References: 41
Page: 157-163
PDF: 115.79 Kb.

Full text


Introduction: Primary immunodeficiencies comprise diseases that impair the immune system. Clinical manifestations are characterized by recurrent respiratory infections, which may be complicated by bronchiectasis, peribronchial thickening, abscesses, bullae, and pulmonary fibrosis. The aim of this study was to determine pulmonary complications in pediatric primary immunodeficiency by type. Results. We included 65 patients, 28 patients with humoral immunodeficiency, four with cellular immunodeficiency, 13 with well-defined syndromes, and 20 with phagocytic defects. Patients with cellular immunodeficiency with symptoms began at an early age, and were diagnosed before one year of age (p = 0.01). Patients with humoral immunodeficiency had more frequent and early respiratory symptoms (p = 0.01). The most common respiratory diseases were acute suppurative otitis media, with sinusitis and pneumonia more common in humoral immunodeficiencies and phagocytic defects. The most common pulmonary complications were bronchiectasis and pulmonary fibrosis interstitial damage, with no statistical difference between primary immunodeficiency type. Pulmonary function tests showed greater impairment in patients with phagocyte defects, but no statistical difference (p = 0.28). The presence of pulmonary complications showed no difference when compared by type of immunodeficiency, agammaglobulinemia only (p = 0.02). Conclusions: Cell immunodeficiencies are diagnosed as early as the onset of symptoms before the patient is one year old. Humoral immunodeficiencies present maximum upper and lower respiratory infections and increased risk of pulmonary complications, especially agammaglobulinemia.

Key words: Primary immunodeficiency, Pediatric, Pulmonary complication.


  1. International Union of Immunological Societies Expert Committee on Primary Immunodeficiencies, Notarangelo LD, Fischer A, et al. Primary immunodeficiency diseases: 2009 update. J Allergy Clin Immunol. 2009;124(6):1161-78.

  2. Wood P, Stanworth S, Burton J, et al. Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin Exp Immunol. 2007;149(3):410-23.

  3. Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies. Clin Exp Immunol. 1999;118 Suppl 1:1-28.

  4. Primary immune deficiency. NIAID (National Institute of Allergy and Infectious Diseases) National Institutes of Health. 2001:1-7.

  5. Wood P. Primary antibody deficiency syndromes. Ann Clin Biochem. 2009;46(Pt 2):99-108.

  6. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92(1):34-48.

  7. Quinti I, Soresina A, Spadaro G, et al. Long-term follow-up and outcome of a large cohort of patients with commonvariable immunodeficiency. J Clin Immunol. 2007;27(3):308-16.

  8. Bonilla FA, Bernstein IL, Khan DA, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol. 2005;94(5 Suppl 1):S1-63.

  9. Agarwal S, Cunningham-Rundles C. Assessment and clinical interpretation of reduced IgG values. Ann Allergy Asthma Immunol. 2007;99(3): 281-3.

  10. Morimoto Y, Routes JM. Immunodeficiency overview. Prim Care Clin Office Pract. 2008;35(1):59-173.

  11. Zelazko M, Carneiro-Sampaio M, Cornejo de Luigi M, et al. Primary immunodeficiency diseases in Latin America: First report from eight countries participating in the LAGID. J Clin Immunol. 1998;18(2):61-6.

  12. Leiva LE, Zelazco M, Oleastro M, et al. Primary Immunodeficiency Diseases in Latin America: The Second Report t of the LAGID1 Registry. J Clin Immunol. 2007;27(1):101-8.

  13. Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med. 1993;86(1):31-42.

  14. Bierry G, MD, Boileau J, Barnig C, et al. Thoracic manifestations of primary humoral immunodeficiency: a comprehensive review. Radiographics. 2009;29(7):1909-20.

  15. Jolles S. The variable in common variable immunodeficiency: a disease of complex phenotypes. J Allergy Clin Immunol Pract. 2013;1(6):545-56.

  16. Lim MS, Elenitoba-Johnson KS. The molecular pathology of primary immunodeficiencies. J Mol Diagn. 2004;6(2):59-83.

  17. Montoya C. Inmunodeficiencias primarias. En: Rugeles MT, Patiño PJ, eds. Inmunología. Una ciencia activa. Colombia: Biogenesis; 2004.

  18. Jones AM, Gaspar HB. Inmunogenetics: changing the face of immunodeficiency. J Clin Pathol. 2000;53(1):60-5.

  19. Oleastro M, Galicchio M, Krasovec S. Inmunodeficiencias primarias. 2001. [Internet] Disponible en: www.emc.alergia.org.ar/enfoq5_1_ 12_2001.pdf.

  20. Abolhassani H, Rezaei N, Mohammadinejad P, Mirminachi B, Hammarstrom L, Aghamohammadi A. Important differences in the diagnostic spectrum of primary immunodeficiency in adults versus children. Expert Rev Clin Immunol 2015 Feb;11(2):289-302.

  21. Al- Herz W, Bousfiha A, Casanova JL, Chatila T et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol. 2014 Apr 22;5:162.

  22. Bonilla PA, Geha RS. Primary immunodeficiency diseases. J Allergy Clin Immunol. 2003;111(2 Suppl):S571-81.

  23. Quartier P, Debré M, De Blic J, et al. Early and prolonged intravenous immunoglobulin therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients. J Pediatr. 1999;134(5):589-96.

  24. Hausser C, Virelizier JL, Buriot D, Griscelli C. Common variable hypogammaglobulinemia in children. Am J Dis Child. 1983;137(9):833-7.

  25. Lederman HM, Winkelstein JA. X-linked agammaglobulinemia: an analysis of 96 patients. Medicine. 1985;64(3):145-56.

  26. Dagli E. Non-cystic fibrosis bronchiectasis. Pediatr Respir Rev. 2000;1(1):64-70.

  27. Gattoni F, Tagliaferri B, Boioli F, Mazzoleni C, Uslenghi CM. [Computerized tomography of the lungs in patients with congenital immunodeficiency. Comparison with clinicoradiologic assessment]. Radiol Med. 1999;98(1-2):26-35.

  28. Obregon RG, Lynch DA, Kaske T, Newell JD Jr, Kirkpatrick CH. Radiologic findings of adult primary immunodeficiency disorders. Contribution of CT. Chest. 1994;106(2):490-5.

  29. Buckley RH. Primary immunodeficiency diseases. En: Adkinson NF, Bochner BS, Yunginger JW, Holgate ST, Busse W, Simons FER, eds. Middleton’s allergy principles and practice. 6.a ed. Filadelfia, PA: Mosby; 2003. p. 1015-42.

  30. Jesenak M, Banovcin P, Jesenakova B, Babusikova E. Pulmonary manifestations of primary immunodeficiency disorders in children. Front Pediatr. 2014; 2: 77. doi: 10.3389/fped.2014.00077.

  31. Winkelstein JA, Marino MC, Ochs H, et al. The X-linked hyper-IgMsyndrome: clinical and immunologic features of 79 patients. Medicine. 2003;82(6):373-84.

  32. Buckley RH. Primary immunodeficiency diseases. En: Adkinson NF, Bochner BS, Yunginger JW, Holgate ST, Busse W, Simons FER, eds. Middleton’s allergy principles and practice. 6.a ed. Filadelfia, PA: Mosby; 2003. p. 1015-42.

  33. Newson T, Chippindale AJ, Cant AJ. Computed tomography scan assessment of lung disease in primary immunodeficiencies. Eur J Pediatr. 1999;158(1):29-31.

  34. Rusconi F, Panisi C, Dellepiane R, Cardinale R, Chini L, Martire B. Pulmonary and sinus diseases in primary humoral immunodeficiencies with chronic productive cough. Arch Dis Child. 2003;88(12):1101-5.

  35. Lederman HM, Winkelstein JA. X-linked agammaglobulinemia: an analysis of 96 patients. Medicine (Baltimore). 1985;64(3):145-56.

  36. Sacher RA; IVIG Advisory Panel. Intravenous immunoglobulin consensus statement. J Allergy Clin Immunol. 2001;108(4 Suppl):S139-46.

  37. Busse PJ, Razvi S, Cunninham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol. 2002;109(6): 1001-4.

  38. Ulrike B, Christian P. Importancia del factor de transformación y crecimiento b en el desarrollo y patología pulmonar. Chest. 2004;125: 754-65.

  39. Mogica Martínez MD, García Lara S, Silva Vera R, et al. [Neumopathies in patients with primary immunodeficiencies in treatment with intravenous gammaglobulin]. Rev Alerg Mex. 2007;54(1):14-9.

  40. Pérez Ruiz E, Pérez Frías J, García Martín FJ, Vázquez López R, González Martínez B, Martínez Valverde A. [Pulmonary symptoms of primary immunodeficiency diseases]. An Esp Pediatr. 1998;48(3): 238-44.

  41. Lai SH, Wong KS, Liao SL. Clinical analysis of bronchiectasis in Taiwanese children. Chang Gung Med J. 2004;27(2):122-8.

>Journals >Gaceta Médica de México >Year 2015, Issue 2

· Journal Index 
· Links 

Copyright 2019